• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于肺部给药的含布洛芬纳米包埋微粒的制备与表征

Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery.

作者信息

Party Petra, Klement Márk László, Szabó-Révész Piroska, Ambrus Rita

机构信息

Interdisciplinary Excellence Centre, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös Street 6, 6720 Szeged, Hungary.

出版信息

Pharmaceutics. 2023 Feb 6;15(2):545. doi: 10.3390/pharmaceutics15020545.

DOI:10.3390/pharmaceutics15020545
PMID:36839867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9966045/
Abstract

A fatal hereditary condition, cystic fibrosis (CF) causes severe lung problems. Ibuprofen (IBU), a non-steroidal anti-inflammatory drug, slows the progression of disease without causing significant side effects. Considering the poor water-solubility of the drug, IBU nanoparticles are beneficial for local pulmonary administration. We aimed to formulate a carrier-free dry powder inhaler containing nanosized IBU. We combined high-performance ultra-sonication and nano spray-drying. IBU was dissolved in ethyl acetate; after that, it was sonicated into a polyvinyl alcohol solution, where it precipitated as nanoparticles. Mannitol and leucine were added when producing dry particles using nano-spray drying. The following investigations were implemented: dynamic light scattering, laser diffraction, surface tension measurement, scanning electron microscopy, X-ray powder diffraction, differential scanning calorimetry, Fourier-transform infrared spectroscopy, in vitro dissolution test, and in vitro aerodynamic assessment (Andersen Cascade Impactor). The particle diameter of the IBU was in the nano range. The spray-dried particles showed a spherical morphology. The drug release was rapid in artificial lung media. The products represented large fine particle fractions and proper aerodynamic diameters. We successfully created an inhalable powder, containing nano-sized IBU. Along with the exceptional aerodynamic performance, the ideal particle size, shape, and drug-release profile might offer a ground-breaking local therapy for CF.

摘要

囊性纤维化(CF)是一种致命的遗传性疾病,会导致严重的肺部问题。布洛芬(IBU)是一种非甾体抗炎药,可减缓疾病进展且无明显副作用。考虑到该药物水溶性差,IBU纳米颗粒有利于局部肺部给药。我们旨在制备一种含纳米级IBU的无载体干粉吸入器。我们结合了高性能超声处理和纳米喷雾干燥技术。将IBU溶解于乙酸乙酯中;之后,将其超声处理至聚乙烯醇溶液中,在其中沉淀形成纳米颗粒。在使用纳米喷雾干燥制备干燥颗粒时加入甘露醇和亮氨酸。进行了以下研究:动态光散射、激光衍射、表面张力测量、扫描电子显微镜、X射线粉末衍射、差示扫描量热法、傅里叶变换红外光谱、体外溶出试验和体外空气动力学评估(安德森撞击器)。IBU的粒径处于纳米范围。喷雾干燥颗粒呈球形形态。在人工肺介质中药物释放迅速。产品表现出较大的细颗粒分数和合适的空气动力学直径。我们成功制备了一种含纳米级IBU的可吸入粉末。连同出色的空气动力学性能,理想的粒径、形状和药物释放曲线可能为CF提供一种开创性的局部治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/15572fda65ca/pharmaceutics-15-00545-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/430ecc06dc06/pharmaceutics-15-00545-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/568eaf98b2e2/pharmaceutics-15-00545-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/7d3f79a92434/pharmaceutics-15-00545-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/a17cf3dd1701/pharmaceutics-15-00545-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/1397afff2a90/pharmaceutics-15-00545-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/bd556a71ad67/pharmaceutics-15-00545-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/15572fda65ca/pharmaceutics-15-00545-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/430ecc06dc06/pharmaceutics-15-00545-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/568eaf98b2e2/pharmaceutics-15-00545-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/7d3f79a92434/pharmaceutics-15-00545-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/a17cf3dd1701/pharmaceutics-15-00545-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/1397afff2a90/pharmaceutics-15-00545-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/bd556a71ad67/pharmaceutics-15-00545-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f67/9966045/15572fda65ca/pharmaceutics-15-00545-g007.jpg

相似文献

1
Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery.用于肺部给药的含布洛芬纳米包埋微粒的制备与表征
Pharmaceutics. 2023 Feb 6;15(2):545. doi: 10.3390/pharmaceutics15020545.
2
Development of extra-fine particles containing nanosized meloxicam for deep pulmonary delivery: In vitro aerodynamic and cell line measurements.开发含纳米美洛昔康的超细颗粒用于肺部深部递送:体外空气动力学和细胞系测量。
Eur J Pharm Sci. 2022 Sep 1;176:106247. doi: 10.1016/j.ejps.2022.106247. Epub 2022 Jun 25.
3
Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.设计、物理化学特性分析和优化有机溶液高级喷雾干燥二棕榈酰磷脂酰胆碱(DPPC)和二棕榈酰磷脂酰乙醇胺聚乙二醇(DPPE-PEG)微米和纳米粒子,用于作为干粉吸入剂气溶胶的靶向呼吸纳米医学递药。
Int J Nanomedicine. 2013;8:275-93. doi: 10.2147/IJN.S30724. Epub 2013 Jan 15.
4
A Novel Combined Dry Powder Inhaler Comprising Nanosized Ketoprofen-Embedded Mannitol-Coated Microparticles for Pulmonary Inflammations: Development, In Vitro-In Silico Characterization, and Cell Line Evaluation.一种新型组合式干粉吸入器,包含用于肺部炎症的纳米尺寸酮洛芬包埋甘露醇包衣微粒:研发、体外-计算机模拟表征及细胞系评估
Pharmaceuticals (Basel). 2024 Jan 7;17(1):75. doi: 10.3390/ph17010075.
5
Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.用于靶向肺部递送的先进喷雾干燥微粒/纳米微粒甘露醇粉末作为干粉吸入器的设计、表征和气溶胶分散性能建模。
J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):81-93. doi: 10.1089/jamp.2013.1078. Epub 2014 Feb 6.
6
Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.含盐酸环丙沙星的干粉吸入系统的物理化学稳定性和雾化性能。
J Pharm Biomed Anal. 2018 Jan 30;148:73-79. doi: 10.1016/j.jpba.2017.09.019. Epub 2017 Sep 22.
7
Investigation of Physico-Chemical Stability and Aerodynamic Properties of Novel "Nano-in-Micro" Structured Dry Powder Inhaler System.新型“微纳复合”结构干粉吸入器系统的物理化学稳定性及空气动力学性质研究
Micromachines (Basel). 2023 Jun 30;14(7):1348. doi: 10.3390/mi14071348.
8
The Effect of Particle Size and Surface Roughness of Spray-Dried Bosentan Microparticles on Aerodynamic Performance for Dry Powder Inhalation.喷雾干燥波生坦微粒的粒径和表面粗糙度对干粉吸入气雾剂动力学性能的影响
Pharmaceutics. 2020 Aug 13;12(8):765. doi: 10.3390/pharmaceutics12080765.
9
Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.先进喷雾干燥化疗 PEG 化磷脂粒子的特性及其在肺癌干粉吸入递药中的气溶胶分散性能。
Eur J Pharm Sci. 2013 Jul 16;49(4):699-711. doi: 10.1016/j.ejps.2013.05.012. Epub 2013 May 23.
10
Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.用于递送酒石酸氢卡巴拉汀的新型干粉吸入制剂的研发。
Int J Pharm. 2016 Mar 30;501(1-2):124-38. doi: 10.1016/j.ijpharm.2016.01.066. Epub 2016 Feb 1.

引用本文的文献

1
Intranasal and Pulmonary Lipid Nanoparticles for Gene Delivery: Turning Challenges into Opportunities.用于基因递送的鼻内和肺部脂质纳米颗粒:将挑战转化为机遇
Int J Nanomedicine. 2025 Jun 23;20:8085-8099. doi: 10.2147/IJN.S517385. eCollection 2025.
2
Development of Mannitol-Based Microparticles for Dry Powder Inhalers: Enhancing Pulmonary Delivery of NSAIDs.用于干粉吸入器的基于甘露醇的微粒的开发:增强非甾体抗炎药的肺部递送。
Pharmaceuticals (Basel). 2025 Jun 19;18(6):923. doi: 10.3390/ph18060923.
3
Nano-Spray-Drying of Cyclodextrin/Ibuprofen Complexes with Aerosolization-Enhancing Additives for Pulmonary Drug Delivery.

本文引用的文献

1
Robust Wet Milling Technique for Producing Micronized Ibuprofen Particles with Improved Solubility and Dissolution.制备具有改善溶出度的微米级布洛芬粒子的稳健湿法研磨技术。
AAPS PharmSciTech. 2022 Dec 15;24(1):16. doi: 10.1208/s12249-022-02480-w.
2
Development of extra-fine particles containing nanosized meloxicam for deep pulmonary delivery: In vitro aerodynamic and cell line measurements.开发含纳米美洛昔康的超细颗粒用于肺部深部递送:体外空气动力学和细胞系测量。
Eur J Pharm Sci. 2022 Sep 1;176:106247. doi: 10.1016/j.ejps.2022.106247. Epub 2022 Jun 25.
3
Particle engineering in dry powders for inhalation.
用于肺部给药的环糊精/布洛芬复合物与雾化增强添加剂的纳米喷雾干燥法
Int J Mol Sci. 2025 May 1;26(9):4320. doi: 10.3390/ijms26094320.
4
Nanoparticle-Based Dry Powder Inhaler Containing Ciprofloxacin for Enhanced Targeted Antibacterial Therapy.含环丙沙星的纳米颗粒干粉吸入器用于增强靶向抗菌治疗
Pharmaceutics. 2025 Apr 7;17(4):486. doi: 10.3390/pharmaceutics17040486.
5
Optimization, In Vitro, and In Silico Characterization of Theophylline Inhalable Powder Using Raffinose-Amino Acid Combination as Fine Co-Spray-Dried Carriers.以棉子糖 - 氨基酸组合作为精细共喷雾干燥载体的茶碱可吸入粉末的优化、体外及计算机模拟表征
Pharmaceutics. 2025 Apr 3;17(4):466. doi: 10.3390/pharmaceutics17040466.
6
Encapsulation of Ibuprofen by Pickering-Stabilized Antibubbles.通过皮克林稳定的抗气泡对布洛芬进行包封。
ACS Omega. 2025 Jan 22;10(7):7131-7141. doi: 10.1021/acsomega.4c10244. eCollection 2025 Feb 25.
7
Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine.吸入疗法中基于纳米颗粒的药物递送系统:改善呼吸医学。
Pharmaceuticals (Basel). 2024 Aug 12;17(8):1059. doi: 10.3390/ph17081059.
8
Preparation and Investigation of a Nanosized Piroxicam Containing Orodispersible Lyophilizate.含纳米吡罗昔康的口腔崩解冻干制剂的制备与研究
Micromachines (Basel). 2024 Apr 15;15(4):532. doi: 10.3390/mi15040532.
9
Investigation of Physico-Chemical Stability and Aerodynamic Properties of Novel "Nano-in-Micro" Structured Dry Powder Inhaler System.新型“微纳复合”结构干粉吸入器系统的物理化学稳定性及空气动力学性质研究
Micromachines (Basel). 2023 Jun 30;14(7):1348. doi: 10.3390/mi14071348.
用于吸入的干粉中的颗粒工程。
Eur J Pharm Sci. 2022 May 1;172:106158. doi: 10.1016/j.ejps.2022.106158. Epub 2022 Mar 4.
4
Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review.囊性纤维化肺部疾病的治疗:全面综述
Antibiotics (Basel). 2021 Apr 23;10(5):486. doi: 10.3390/antibiotics10050486.
5
Formulation and In Vitro and In Silico Characterization of "Nano-in-Micro" Dry Powder Inhalers Containing Meloxicam.含美洛昔康的“微纳”干粉吸入剂的制剂及其体外和计算机模拟表征
Pharmaceutics. 2021 Feb 3;13(2):211. doi: 10.3390/pharmaceutics13020211.
6
Dry Powder for Pulmonary Delivery: A Comprehensive Review.肺部给药干粉剂:全面综述
Pharmaceutics. 2020 Dec 28;13(1):31. doi: 10.3390/pharmaceutics13010031.
7
Advances in Pulmonary Drug Delivery.肺部给药的进展
Pharmaceutics. 2020 Sep 23;12(10):911. doi: 10.3390/pharmaceutics12100911.
8
The future of cystic fibrosis care: a global perspective.囊性纤维化护理的未来:全球视角。
Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27.
9
Targeting airway inflammation in cystic fibrosis.靶向囊性纤维化中的气道炎症。
Expert Rev Respir Med. 2019 Nov;13(11):1041-1055. doi: 10.1080/17476348.2019.1666715. Epub 2019 Oct 10.
10
Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery.载有美洛昔康的喷雾干燥无孔和大孔颗粒的制剂及比较研究用于肺部药物传递。
Int J Pharm. 2019 Mar 25;559:68-75. doi: 10.1016/j.ijpharm.2019.01.034. Epub 2019 Jan 21.